The treatment of metastatic breast cancer with 5-fluorouracil and leucovorin.
Allegra
C J
CJ
Clinical Pharmacology Branch, National Cancer Institute, Bethesda, Maryland 20892.
Egan
G F
GF
Drake
J C
JC
Steinberg
S M
SM
Swain
S M
SM
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D009362:Neoplasm Metastasis; D013940:Thymidylate Synthase / Q000037:antagonists & inhibitors
D013940:Thymidylate Synthase; D002955:Leucovorin; D005472:Fluorouracil